Literature DB >> 21849455

Y-box-binding protein 1 interacts with hepatitis C virus NS3/4A and influences the equilibrium between viral RNA replication and infectious particle production.

Laurent Chatel-Chaix1, Pierre Melançon, Marie-Ève Racine, Martin Baril, Daniel Lamarre.   

Abstract

The hepatitis C virus (HCV) NS3/4A protein has several essential roles in the virus life cycle, most probably through dynamic interactions with host factors. To discover cellular cofactors that are co-opted by HCV for its replication, we elucidated the NS3/4A interactome using mass spectrometry and identified Y-box-binding protein 1 (YB-1) as an interacting partner of NS3/4A protein and HCV genomic RNA. Importantly, silencing YB-1 expression decreased viral RNA replication and severely impaired the propagation of the infectious HCV molecular clone JFH-1. Immunofluorescence studies further revealed a drastic HCV-dependent redistribution of YB-1 to the surface of the lipid droplets, an important organelle for HCV assembly. Core and NS3 protein-dependent polyprotein maturation were shown to be required for YB-1 relocalization. Unexpectedly, YB-1 knockdown cells showed the increased production of viral infectious particles while HCV RNA replication was impaired. Our data support that HCV hijacks YB-1-containing ribonucleoparticles and that YB-1-NS3/4A-HCV RNA complexes regulate the equilibrium between HCV RNA replication and viral particle production.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21849455      PMCID: PMC3194978          DOI: 10.1128/JVI.00719-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  56 in total

Review 1.  New and experimental therapies for HCV.

Authors:  Arema A Pereira; Ira M Jacobson
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-07       Impact factor: 46.802

2.  Association of hepatitis C virus replication complexes with microtubules and actin filaments is dependent on the interaction of NS3 and NS5A.

Authors:  Chao-Kuen Lai; King-Song Jeng; Keigo Machida; Michael M C Lai
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

3.  Y-box-binding protein YB-1 identifies high-risk patients with primary breast cancer benefiting from rapidly cycled tandem high-dose adjuvant chemotherapy.

Authors:  Oleg Gluz; Karin Mengele; Manfred Schmitt; Ronald Kates; Raihana Diallo-Danebrock; Frauke Neff; Hans-Dieter Royer; Niels Eckstein; Svjetlana Mohrmann; Evelyn Ting; Marion Kiechle; Christopher Poremba; Ulrike Nitz; Nadia Harbeck
Journal:  J Clin Oncol       Date:  2009-11-09       Impact factor: 44.544

4.  Hepatitis C virus core protein induces lipid droplet redistribution in a microtubule- and dynein-dependent manner.

Authors:  Steeve Boulant; Mark W Douglas; Laura Moody; Agata Budkowska; Paul Targett-Adams; John McLauchlan
Journal:  Traffic       Date:  2008-05-17       Impact factor: 6.215

5.  Riboproteomic analysis of polypeptides interacting with the internal ribosome-entry site element of foot-and-mouth disease viral RNA.

Authors:  Almudena Pacheco; Sandrine Reigadas; Encarnación Martínez-Salas
Journal:  Proteomics       Date:  2008-11       Impact factor: 3.984

6.  MAVS dimer is a crucial signaling component of innate immunity and the target of hepatitis C virus NS3/4A protease.

Authors:  Martin Baril; Marie-Eve Racine; François Penin; Daniel Lamarre
Journal:  J Virol       Date:  2008-11-26       Impact factor: 5.103

7.  Profiling YB-1 target genes uncovers a new mechanism for MET receptor regulation in normal and malignant human mammary cells.

Authors:  M R Finkbeiner; A Astanehe; K To; A Fotovati; A H Davies; Y Zhao; H Jiang; A L Stratford; A Shadeo; C Boccaccio; P Comoglio; P R Mertens; P Eirew; A Raouf; C J Eaves; S E Dunn
Journal:  Oncogene       Date:  2009-01-19       Impact factor: 9.867

8.  Translational activation of snail1 and other developmentally regulated transcription factors by YB-1 promotes an epithelial-mesenchymal transition.

Authors:  Valentina Evdokimova; Cristina Tognon; Tony Ng; Peter Ruzanov; Natalya Melnyk; Dieter Fink; Alexey Sorokin; Lev P Ovchinnikov; Elai Davicioni; Timothy J Triche; Poul H B Sorensen
Journal:  Cancer Cell       Date:  2009-05-05       Impact factor: 31.743

9.  Nuclear detection of Y-box protein-1 (YB-1) closely associates with progesterone receptor negativity and is a strong adverse survival factor in human breast cancer.

Authors:  Edgar Dahl; Abdelaziz En-Nia; Frank Wiesmann; Renate Krings; Sonja Djudjaj; Elisabeth Breuer; Thomas Fuchs; Peter J Wild; Arndt Hartmann; Sandra E Dunn; Peter R Mertens
Journal:  BMC Cancer       Date:  2009-11-24       Impact factor: 4.430

10.  Trans-complementation of an NS2 defect in a late step in hepatitis C virus (HCV) particle assembly and maturation.

Authors:  MinKyung Yi; Yinghong Ma; Jeremy Yates; Stanley M Lemon
Journal:  PLoS Pathog       Date:  2009-05-01       Impact factor: 6.823

View more
  22 in total

1.  A novel recombinant papillomavirus genome enabling in vivo RNA interference reveals that YB-1, which interacts with the viral regulatory protein E2, is required for CRPV-induced tumor formation in vivo.

Authors:  Natalie Leiprecht; Ekaterina Notz; Johanna Schuetz; Juliane Haedicke; Frank Stubenrauch; Thomas Iftner
Journal:  Am J Cancer Res       Date:  2014-05-26       Impact factor: 6.166

2.  YB-1 stabilizes HIV-1 genomic RNA and enhances viral production.

Authors:  Xin Mu; Wei Li; Xinlu Wang; Guangxia Gao
Journal:  Protein Cell       Date:  2013-04-15       Impact factor: 14.870

3.  A murine retrovirus co-Opts YB-1, a translational regulator and stress granule-associated protein, to facilitate virus assembly.

Authors:  Darrin V Bann; Andrea R Beyer; Leslie J Parent
Journal:  J Virol       Date:  2014-02-05       Impact factor: 5.103

4.  Establishment of a novel cell line for the enhanced production of recombinant adeno-associated virus vectors for gene therapy.

Authors:  Stifani Satkunanathan; Jun Wheeler; Robin Thorpe; Yuan Zhao
Journal:  Hum Gene Ther       Date:  2014-09-11       Impact factor: 5.695

5.  Modulation of hepatitis C virus RNA abundance and virus release by dispersion of processing bodies and enrichment of stress granules.

Authors:  Cara T Pager; Sylvia Schütz; Teresa M Abraham; Guangxiang Luo; Peter Sarnow
Journal:  Virology       Date:  2012-11-09       Impact factor: 3.616

6.  Neuralized E3 Ubiquitin Protein Ligase 3 Is an Inducible Antiviral Effector That Inhibits Hepatitis C Virus Assembly by Targeting Viral E1 Glycoprotein.

Authors:  Yanan Zhao; Xuezhi Cao; Mingzhe Guo; Xuesong Wang; Tao Yu; Liqing Ye; Lin Han; Lei Hei; Wanyin Tao; Yimin Tong; Yongfen Xu; Jin Zhong
Journal:  J Virol       Date:  2018-10-12       Impact factor: 5.103

7.  A host YB-1 ribonucleoprotein complex is hijacked by hepatitis C virus for the control of NS3-dependent particle production.

Authors:  Laurent Chatel-Chaix; Marie-Anne Germain; Alena Motorina; Éric Bonneil; Pierre Thibault; Martin Baril; Daniel Lamarre
Journal:  J Virol       Date:  2013-08-28       Impact factor: 5.103

8.  Elucidating novel hepatitis C virus-host interactions using combined mass spectrometry and functional genomics approaches.

Authors:  Marie-Anne Germain; Laurent Chatel-Chaix; Bridget Gagné; Éric Bonneil; Pierre Thibault; Fabrine Pradezynski; Benoît de Chassey; Laurène Meyniel-Schicklin; Vincent Lotteau; Martin Baril; Daniel Lamarre
Journal:  Mol Cell Proteomics       Date:  2013-10-29       Impact factor: 5.911

Review 9.  Host restriction factors for hepatitis C virus.

Authors:  Li-Ya Zhou; Lei-Liang Zhang
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

10.  Y-Box Binding Protein 1 Stabilizes Hepatitis C Virus NS5A via Phosphorylation-Mediated Interaction with NS5A To Regulate Viral Propagation.

Authors:  Wei-Ting Wang; Tsung-Yuan Tsai; Chi-Hong Chao; Bo-Ying Lai; Yan-Hwa Wu Lee
Journal:  J Virol       Date:  2015-09-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.